BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 21383543)

  • 1. DNA hypermethylation of microRNA-34b/c has prognostic value for stage Ⅰ non-small cell lung cancer.
    Wang Z; Chen Z; Gao Y; Li N; Li B; Tan F; Tan X; Lu N; Sun Y; Sun J; Sun N; He J
    Cancer Biol Ther; 2011 Mar; 11(5):490-6. PubMed ID: 21383543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The association between miR-34 dysregulation and distant metastases formation in lung adenocarcinoma.
    Daugaard I; Knudsen A; Kjeldsen TE; Hager H; Hansen LL
    Exp Mol Pathol; 2017 Jun; 102(3):484-491. PubMed ID: 28512015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined Effect of Metastasis-Related MicroRNA, miR-34 and miR-124 Family, Methylation on Prognosis of Non-Small-Cell Lung Cancer.
    Kim YH; Lee WK; Lee EB; Son JW; Kim DS; Park JY
    Clin Lung Cancer; 2017 Jan; 18(1):e13-e20. PubMed ID: 27444357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-34a as a prognostic marker of relapse in surgically resected non-small-cell lung cancer.
    Gallardo E; Navarro A; Viñolas N; Marrades RM; Diaz T; Gel B; Quera A; Bandres E; Garcia-Foncillas J; Ramirez J; Monzo M
    Carcinogenesis; 2009 Nov; 30(11):1903-9. PubMed ID: 19736307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome structure-based screening identified epigenetically silenced microRNA associated with invasiveness in non-small-cell lung cancer.
    Watanabe K; Emoto N; Hamano E; Sunohara M; Kawakami M; Kage H; Kitano K; Nakajima J; Goto A; Fukayama M; Nagase T; Yatomi Y; Ohishi N; Takai D
    Int J Cancer; 2012 Jun; 130(11):2580-90. PubMed ID: 21702040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequent methylation and oncogenic role of microRNA-34b/c in small-cell lung cancer.
    Tanaka N; Toyooka S; Soh J; Kubo T; Yamamoto H; Maki Y; Muraoka T; Shien K; Furukawa M; Ueno T; Asano H; Tsukuda K; Aoe K; Miyoshi S
    Lung Cancer; 2012 Apr; 76(1):32-8. PubMed ID: 22047961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic impact of miR-34b/c DNA methylation, gene expression, and promoter polymorphism in HPV-negative oral squamous cell carcinomas.
    Supic G; Stefik D; Ivkovic N; Sami A; Zeljic K; Jovic S; Kozomara R; Vojvodic D; Stosic S
    Sci Rep; 2022 Jan; 12(1):1296. PubMed ID: 35079080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic inactivation of microRNA-34b/c predicts poor disease-free survival in early-stage lung adenocarcinoma.
    Nadal E; Chen G; Gallegos M; Lin L; Ferrer-Torres D; Truini A; Wang Z; Lin J; Reddy RM; Llatjos R; Escobar I; Moya J; Chang AC; Cardenal F; Capellà G; Beer DG
    Clin Cancer Res; 2013 Dec; 19(24):6842-52. PubMed ID: 24130071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-34b functions as a tumor suppressor and acts as a nodal point in the feedback loop with Met.
    Wang LG; Ni Y; Su BH; Mu XR; Shen HC; Du JJ
    Int J Oncol; 2013 Mar; 42(3):957-62. PubMed ID: 23314612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation between insulin-like growth factor-binding protein-3 promoter methylation and prognosis of patients with stage I non-small cell lung cancer.
    Chang YS; Wang L; Liu D; Mao L; Hong WK; Khuri FR; Lee HY
    Clin Cancer Res; 2002 Dec; 8(12):3669-75. PubMed ID: 12473575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methylation Status of miR-34a and miR-126 in Non-Small Cell Lung Cancer (NSCLC) Tumor Tissues.
    Mehrzad N; Zamani MS; Rahimi A; Shamaei M; Karimipoor M
    Iran Biomed J; 2024 Jan; 28(1):53-8. PubMed ID: 38445462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypermethylation of the death-associated protein (DAP) kinase promoter and aggressiveness in stage I non-small-cell lung cancer.
    Tang X; Khuri FR; Lee JJ; Kemp BL; Liu D; Hong WK; Mao L
    J Natl Cancer Inst; 2000 Sep; 92(18):1511-6. PubMed ID: 10995806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between TP53 genetic polymorphisms and the methylation and expression of miR-34a, 34b/c in colorectal cancer tissues.
    Jun HH; Kwack K; Lee KH; Kim JO; Park HS; Ryu CS; Lee JY; Ko D; Kim JW; Kim NK
    Oncol Lett; 2019 May; 17(5):4726-4734. PubMed ID: 30944658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic signature of protocadherin 10 methylation in curatively resected pathological stage I non-small-cell lung cancer.
    Harada H; Miyamoto K; Yamashita Y; Taniyama K; Mihara K; Nishimura M; Okada M
    Cancer Med; 2015 Oct; 4(10):1536-46. PubMed ID: 26276761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic inactivation of DAPK1, p14ARF, mir-34a and -34b/c in acute promyelocytic leukaemia.
    Ng HY; Wan TS; So CC; Chim CS
    J Clin Pathol; 2014 Jul; 67(7):626-31. PubMed ID: 24811488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Down-regulation of microRNA-181b is a potential prognostic marker of non-small cell lung cancer.
    Yang J; Liu H; Wang H; Sun Y
    Pathol Res Pract; 2013 Aug; 209(8):490-4. PubMed ID: 23827213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypermethylation of potential tumor suppressor miR-34b/c is correlated with late clinical stage in patients with soft tissue sarcomas.
    Xie Y; Zong P; Wang W; Liu D; Li B; Wang Y; Hu J; Ren Y; Qi Y; Cui X; Chen Y; Liu C; Li F
    Exp Mol Pathol; 2015 Jun; 98(3):446-54. PubMed ID: 25773680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low miR-145 silenced by DNA methylation promotes NSCLC cell proliferation, migration and invasion by targeting mucin 1.
    Ye Z; Shen N; Weng Y; Li K; Hu L; Liao H; An J; Liu L; Lao S; Cai S
    Cancer Biol Ther; 2015; 16(7):1071-9. PubMed ID: 25961369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Up-Regulation of miR-21 Expression Predicate Advanced Clinicopathological Features and Poor Prognosis in Patients with Non-Small Cell Lung Cancer.
    Tian L; Shan W; Zhang Y; Lv X; Li X; Wei C
    Pathol Oncol Res; 2016 Jan; 22(1):161-7. PubMed ID: 26453197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Methylation of some miRNA genes is involved in the regulation of their target genes RAR-beta2 and NKIRAS1 expression in lung cancer].
    Khodyrev DS; Pronina IV; Rykov SV; Beresneva EV; Fridman MV; Kazubskaia TP; Loginov VI; Braga ÉA
    Mol Biol (Mosk); 2012; 46(5):773-85. PubMed ID: 23156677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.